logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Vilin Bio Med Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    78871
    INE0L4V01013
    16.3727599
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    VILINBIO
    197.5
    33.06
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0.12
    10
    0
     
Halder Venture standalone net profit rises 42.53% in the March 2024 quarter
May 31,2024
Net profit of Halder Venture rose 42.53% to Rs 1.24 crore in the quarter ended March 2024 as against Rs 0.87 crore during the previous quarter ended March 2023. Sales rose 83.92% to Rs 42.21 crore in the quarter ended March 2024 as against Rs 22.95 crore during the previous quarter ended March 2023.

For the full year,net profit rose 138.18% to Rs 1.31 crore in the year ended March 2024 as against Rs 0.55 crore during the previous year ended March 2023. Sales rose 196.98% to Rs 94.47 crore in the year ended March 2024 as against Rs 31.81 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales42.2122.95 84 94.4731.81 197
OPM %6.495.71 -3.830.69 -
PBDT1.831.24 48 2.090.92 127
PBT1.761.20 47 1.880.77 144
NP1.240.87 43 1.310.55 138